Haemophilia a patients are not at increased risk of hepatitis a virus infection : an Egyptian experience
المؤلفون المشاركون
al-Gohary, Iman A. M.
al-Ghani, Shirin M. A.
al-Hadari, Shirin F.
Tantawi, Azzah A. G.
المصدر
The Egyptian Journal of Medical Human Genetics
العدد
المجلد 13، العدد 1 (30 إبريل/نيسان 2012)، ص ص. 93-97، 5ص.
الناشر
الجمعية المصرية للأمراض الوراثية
تاريخ النشر
2012-04-30
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الموضوعات
الملخص EN
Background : Hepatitis A virus (HAV) infection is endemic in Egypt.
Hemophiliacs are at risk of transmission through exposure to blood products.
We evaluated the seroprevalence of hepatitis A in Egyptian patients with haemophilia A as well as the safety and immunogenicity of subcutaneous hepatitis A vaccine in hemophiliacs'.
Methods : 182 male children and adolescents were studied (82 patients with moderate and severe haemophilia A and 100 healthy controls).
Screening for anti-HAV antibody was done and seronegative subjects received hepatitis A vaccine (Havri at a dose of 720 Elisa Units at 0 and 6 months, given subcutaneously in hemophiliacs' and intramuscularly for controls.
Seroconversion was assessed 2 months after the second vaccine dose by anti-HAV IgG.
Results : seroprevalence of HAV antibodies was 87.6 % among hemophiliacs and 90 % among the control group.
Seronegative children (mean age 4.4 ± 3.71 years) were significantly younger than seropositive children (mean age 10.2 ± 3.86 years).
Hepatitis A vaccine was given to 10 non immune haemophilia patients and 10 controls.
The vaccine was well tolerated with local side effects including pain in 40 % and erythema in 20 % of hemophiliacs' versus 20 % for pain and erythema in the control group.
All patients and controls developed seroconversion 2 months after the second dose ; with no significant difference as regards the titre of anti-HAV IgG (351.4 ± 65.0 IU / L for hemophiliacs and 367.0 ± 132.3 IU / L for controls Conclusion : HAV infection occurs early in life in Egyptian children, necessitating hepatitis A vaccination in early life.
The vaccine is safe and effective when given subcutaneous in hemophiliacs'.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Tantawi, Azzah A. G.& al-Gohary, Iman A. M.& al-Ghani, Shirin M. A.& al-Hadari, Shirin F.. 2012. Haemophilia a patients are not at increased risk of hepatitis a virus infection : an Egyptian experience. The Egyptian Journal of Medical Human Genetics،Vol. 13, no. 1, pp.93-97.
https://search.emarefa.net/detail/BIM-312932
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Tantawi, Azzah A. G.…[et al.]. Haemophilia a patients are not at increased risk of hepatitis a virus infection : an Egyptian experience. The Egyptian Journal of Medical Human Genetics Vol. 13, no. 1 (2012), pp.93-97.
https://search.emarefa.net/detail/BIM-312932
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Tantawi, Azzah A. G.& al-Gohary, Iman A. M.& al-Ghani, Shirin M. A.& al-Hadari, Shirin F.. Haemophilia a patients are not at increased risk of hepatitis a virus infection : an Egyptian experience. The Egyptian Journal of Medical Human Genetics. 2012. Vol. 13, no. 1, pp.93-97.
https://search.emarefa.net/detail/BIM-312932
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 97
رقم السجل
BIM-312932
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر